Literature DB >> 2100690

Introduction: lipids and coronary disease--resolved and unresolved problems.

M F Oliver1.   

Abstract

To my mind, there are more unresolved problems regarding lipids and cardiovascular diseases than those which have been settled. While this may seem disappointing after 40 years of intensive research, the progress which has been made is remarkable and impressive. It is appropriate, therefore, to begin an introduction by outlining the issues which have been resolved and which are more or less internationally agreed. In doing so, I shall deliberately not digress into causes of coronary heart disease (CHD) other than lipids, even though other influences may be as or more important in relation to its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2100690     DOI: 10.1093/oxfordjournals.bmb.a072443

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  2 in total

1.  Economic evaluation of pharmaceuticals: a critical appraisal of seven studies on cholesterol-lowering agents.

Authors:  P Gazzaniga; L Garattini
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

2.  Contributions of Streptococcus mutans Cnm and PA antigens to aggravation of non-alcoholic steatohepatitis in mice.

Authors:  Shuhei Naka; Rina Hatakeyama; Yukiko Takashima; Michiyo Matsumoto-Nakano; Ryota Nomura; Kazuhiko Nakano
Journal:  Sci Rep       Date:  2016-11-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.